Table 3.
Treatments1 |
P-value |
||||||||
---|---|---|---|---|---|---|---|---|---|
NC | PC | V500 | V1,000 | V1,500 | SEM11 | ANOVA | Linear | Quadratic | |
UA2 (mg/DL) | 7.21 | 6.61 | 5.79 | 8.28 | 8.22 | 0.35 | 0.137 | 0.233 | 0.617 |
Alt3,12 (IU/L) | 6.06 | 5.84 | 6.09 | 6.90 | 7.28 | 0.26 | 0.391 | 0.020 | 0.193 |
Albumin (g/L) | 16.33 | 16.15 | 15.24 | 16.63 | 16.89 | 0.23 | 0.209 | 0.361 | 0.612 |
Ast4,13 (IU/L) | 189.13 | 177.47 | 178.76 | 189.23 | 193.25 | 7.23 | 0.943 | 0.040 | 0.260 |
Cho5 (mg/DL) | 116.70 | 115.59 | 105.63 | 119.11 | 113.75 | 2.30 | 0.407 | 0.820 | 0.956 |
Crea6 (mg/DL) | 0.20 | 0.20 | 0.19 | 0.20 | 0.19 | 0.01 | 0.919 | 0.753 | 0.904 |
Ggt7 (IU/L) | 10.68 | 10.89 | 10.74 | 9.24 | 9.07 | 0.36 | 0.341 | 0.068 | 0.362 |
Glu8 (mg/DL) | 258.73 | 266.61 | 246.82 | 259.72 | 266.62 | 3.49 | 0.371 | 0.821 | 0.535 |
TP9 (g/L) | 26.89 | 26.80 | 24.98 | 26.96 | 26.36 | 0.43 | 0.553 | 0.906 | 0.915 |
Trig10(mg/DL) | 58.69 | 63.96 | 47.25 | 69.20 | 62.09 | 3.55 | 0.379 | 0.776 | 0.929 |
Urea (mg/DL) | 3.24 | 4.14 | 3.75 | 4.72 | 3.99 | 0.20 | 0.216 | 0.844 | 0.959 |
NC – Control diet, without growth promoter antimicrobials; PC – Control diet, added 0.12g/ton of Enramycin (8%); 500 - Control diet, added 500 g/ton of Viligen; 1,000 - Control diet, added 1,000 g/ton of Viligen; 1,500 - Control diet, added 1,500 g/ton of Viligen.
Uric Acid.
Alanine Amino transferase.
Aspartate Amino Transferase.
Cholesterol.
Creatinine.
Gama GT.
Glucose.
Total protein.
Triglycerides.
SEM = Standard error of the mean.
Linear effect (P < 0.05) of the treatments on the ALT (y=1.0251x + 5.7578 R² = 0.9595) 13Linear effect (P< 0.05) of the treatments on the AST (y=11.562x + 176 R² = 0.9224).